<p>The changes in the parameters between 0 and 48 weeks were described as the mean (95% confidence interval) and were analyzed using an unpaired <i>t</i>-test* or Mann-Whitney test†.</p><p>Changes in clinical parameters at 48 weeks relative to baseline values.</p
<p>Baseline and evolution of the biological parameters of the 50 patients with the 3 time-point avai...
<p>Lipid parameters and Renal Function: Baseline values and changes at week 48.</p
Clinical parameters of the two study groups at the baseline and during follow-up.</p
<p>The changes in the parameters between 0 and 48 weeks were described as the mean (95% confidence i...
<p>Values are mean with 95% confidence intervals; negative values indicate improvement.</p
<p>Date are shown as median and range unless stated otherwise</p><p>a: p<0.05 (Mann-Whitney Test)</p...
a<p>Mann-Whitney U-test, <sup>b</sup>Kruskal-Wallis test, (N = 143).</p><p>Changes in mean scores, t...
<p>The parameters are described as “mean ± SD” at 0, 24, and 48 weeks. The differences in parameters...
<p>Changes of clinical and laboratory parameters of the two groups during 12 months.</p
<p><i>Values are mean (95% CI) unless otherwise stated.</i></p>*<p><i>Residuals show slight deviatio...
<p>All associations adjusted for age, sex and high-risk sibling status.</p><p># Tests whether change...
<p>Values are given as Mean±SEM. Statistical significance was assessed using Mann Whitney test and F...
<p>All parameters were adjusted for age, BMI and the baseline parameter and represented as means (95...
†<p>Mann-Whitney U test between healthy and patients with CP before treatment.</p>‡<p>Mann-Whitney U...
<p>Blue dashed line = placebo-treated patients. Black solid line = itraconazole-treated patients. 95...
<p>Baseline and evolution of the biological parameters of the 50 patients with the 3 time-point avai...
<p>Lipid parameters and Renal Function: Baseline values and changes at week 48.</p
Clinical parameters of the two study groups at the baseline and during follow-up.</p
<p>The changes in the parameters between 0 and 48 weeks were described as the mean (95% confidence i...
<p>Values are mean with 95% confidence intervals; negative values indicate improvement.</p
<p>Date are shown as median and range unless stated otherwise</p><p>a: p<0.05 (Mann-Whitney Test)</p...
a<p>Mann-Whitney U-test, <sup>b</sup>Kruskal-Wallis test, (N = 143).</p><p>Changes in mean scores, t...
<p>The parameters are described as “mean ± SD” at 0, 24, and 48 weeks. The differences in parameters...
<p>Changes of clinical and laboratory parameters of the two groups during 12 months.</p
<p><i>Values are mean (95% CI) unless otherwise stated.</i></p>*<p><i>Residuals show slight deviatio...
<p>All associations adjusted for age, sex and high-risk sibling status.</p><p># Tests whether change...
<p>Values are given as Mean±SEM. Statistical significance was assessed using Mann Whitney test and F...
<p>All parameters were adjusted for age, BMI and the baseline parameter and represented as means (95...
†<p>Mann-Whitney U test between healthy and patients with CP before treatment.</p>‡<p>Mann-Whitney U...
<p>Blue dashed line = placebo-treated patients. Black solid line = itraconazole-treated patients. 95...
<p>Baseline and evolution of the biological parameters of the 50 patients with the 3 time-point avai...
<p>Lipid parameters and Renal Function: Baseline values and changes at week 48.</p
Clinical parameters of the two study groups at the baseline and during follow-up.</p